Immupharma PLC Notification of Full Year Results (7012F)
22 May 2017 - 4:01PM
UK Regulatory
TIDMIMM
RNS Number : 7012F
Immupharma PLC
22 May 2017
22 MAY 2017
ImmuPharma PLC
("ImmuPharma" or the "Company")
NOTIFICATION OF FULL YEAR RESULTS
Date: 1 June 2017
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and
development company, confirms that it will be announcing its full
year results for the year ended 31 December 2016 on Thursday 1 June
2017.
-Ends-
For further information please
contact:
+ 44 (0) 20
ImmuPharma plc (www.immupharma.org) 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor
Relations + 44 (0) 7721
Twitter: @immupharma 413496
Northland Capital Partners Limited
(Joint Broker)
Patrick Claridge, David Hignell,
Corporate Finance +44 (0)20 3861
Rob Rees, Corporate Broking 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKMGMKZLVGNZM
(END) Dow Jones Newswires
May 22, 2017 02:01 ET (06:01 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024